Profile | GDS4284 / 242226_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 247.232 | 53 |
GSM687648 | Patient 402 control | 116.803 | 38 |
GSM687653 | Patient 403 control | 194.914 | 49 |
GSM687658 | Patient 404 control | 43.1317 | 21 |
GSM687663 | Patient 411 control | 91.1175 | 31 |
GSM687668 | Patient 422 control | 198.568 | 49 |
GSM687673 | Patient 424 control | 211.928 | 48 |
GSM687678 | Patient 425 control | 284.193 | 54 |
GSM687683 | Patient 427 control | 150.951 | 40 |
GSM687688 | Patient 428 control | 37.4091 | 20 |
GSM687695 | Patient 441 control | 171.164 | 36 |
GSM687699 | Patient 443 control | 118.218 | 33 |
GSM687704 | Patient 444 control | 223.79 | 51 |
GSM687707 | Patient 448 control | 45.5926 | 19 |
GSM687712 | Patient 449 control | 122.005 | 38 |
GSM687719 | Patient 450 control | 23.1487 | 11 |
GSM687724 | Patient 451 control | 28.8904 | 14 |
GSM687728 | Patient 452 control | 158.08 | 42 |
GSM687646 | Patient 401 treated 24h | 39.1813 | 20 |
GSM687649 | Patient 402 treated 24h | 216.394 | 51 |
GSM687665 | Patient 411 treated 24h | 148.172 | 40 |
GSM687651 | Patient 402 treated 4 weeks | 149.952 | 41 |
GSM687667 | Patient 411 treated 4 weeks | 56.0483 | 24 |
GSM687670 | Patient 422 treated 24h | 110.356 | 35 |
GSM687671 | Patient 422 treated 4 weeks | 139.813 | 42 |
GSM687654 | Patient 403 treated 24h | 119.162 | 40 |
GSM687675 | Patient 424 treated 24h | 39.5446 | 18 |
GSM687685 | Patient 427 treated 24h | 136.751 | 40 |
GSM687656 | Patient 403 treated 4 weeks | 144.545 | 44 |
GSM687677 | Patient 424 treated 4 weeks | 64.2948 | 27 |
GSM687687 | Patient 427 treated 4 weeks | 172.981 | 47 |
GSM687692 | Patient 428 treated 4h | 79.5301 | 30 |
GSM687716 | Patient 449 treated 4h | 193.777 | 49 |
GSM687722 | Patient 450 treated 4h | 77.7441 | 27 |
GSM687680 | Patient 425 treated 24h | 28.4714 | 16 |
GSM687690 | Patient 428 treated 24h | 139.774 | 42 |
GSM687700 | Patient 443 treated 24h | 137.896 | 33 |
GSM687705 | Patient 444 treated 24h | 135.712 | 42 |
GSM687714 | Patient 449 treated 24h | 24.8255 | 15 |
GSM687721 | Patient 450 treated 24h | 18.7608 | 8 |
GSM687682 | Patient 425 treated 4 weeks | 59.3537 | 26 |
GSM687694 | Patient 428 treated 4 weeks | 26.5627 | 17 |
GSM687702 | Patient 443 treated 4 weeks | 175.414 | 43 |
GSM687718 | Patient 449 treated 4 weeks | 77.298 | 29 |
GSM687723 | Patient 450 treated 4 weeks | 231.279 | 50 |
GSM687661 | Patient 404 treated 4h | 59.4618 | 25 |
GSM687710 | Patient 448 treated 4h | 79.6743 | 30 |
GSM687726 | Patient 451 treated 4h | 100.709 | 31 |
GSM687730 | Patient 452 treated 4h | 531.936 | 57 |
GSM687660 | Patient 404 treated 24h | 187.845 | 43 |
GSM687697 | Patient 441 treated 24h | 344.535 | 54 |
GSM687709 | Patient 448 treated 24h | 103.993 | 33 |
GSM687725 | Patient 451 treated 24h | 77.472 | 26 |
GSM687729 | Patient 452 treated 24h | 107.314 | 29 |
GSM687727 | Patient 451 treated 4 weeks | 252.456 | 50 |
GSM687731 | Patient 452 treated 4 weeks | 198.634 | 46 |